mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.9 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.9 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.9 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.0091 |
0.9 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |